Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Elena-Laura ANTOHI"'
Autor:
Michele Correale, Elena‐Laura Antohi, Riccardo M. Inciardi, Pietro Mazzeo, Stefano Coiro, Shiro Ishihara, Renata Petroni, Francesco Monitillo, Marta Leone, Marco Triggiani, Chaudhry M.S. Sarwar, Hans‐Dirk Dungen, Khawaja M. Talha, Natale D. Brunetti, Javed Butler, Savina Nodari, Master Program Group on Drug Development for Heart Failure
Publikováno v:
ESC Heart Failure, Vol 10, Iss 3, Pp 2066-2073 (2023)
Abstract Aims Sodium‐glucose cotransporter type 2 inhibitors (SGLT‐2i) represent a unique class of anti‐hyperglycaemic agents for type 2 diabetes mellitus that selectively inhibit renal glucose reabsorption, thereby increasing urinary excretion
Externí odkaz:
https://doaj.org/article/de59c9a117ce41d4beb61fc436b157b3
Autor:
Razvan I. Radu, Tuvia Ben Gal, Magdy Abdelhamid, Elena‐Laura Antohi, Marianna Adamo, Andrew P. Ambrosy, Oliviana Geavlete, Yuri Lopatin, Alexander Lyon, Oscar Miro, Marco Metra, John Parissis, Sean P. Collins, Stefan D. Anker, Ovidiu Chioncel
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 4717-4736 (2021)
Abstract Cardiogenic shock (CS) is a complex multifactorial clinical syndrome, developing as a continuum, and progressing from the initial insult (underlying cause) to the subsequent occurrence of organ failure and death. There is a large phenotypic
Externí odkaz:
https://doaj.org/article/d655f69a7f10400792deeb84af7d8578
Publikováno v:
Romanian Journal of Cardiology, Vol 31, Iss 2, Pp 351-359 (2021)
Background: Advanced heart failure (HF) represents a clinical entity encompassing severely symptomatic HF with severely dysfunctional left ventricles (LV). The single most important parameter for defining severe LV dysfunction and indicating the pres
Externí odkaz:
https://doaj.org/article/35cbf3cc889f40778c33b79bf7ea777b
Autor:
Serban Mihaileanu, Elena‐Laura Antohi
Publikováno v:
ESC Heart Failure, Vol 7, Iss 5, Pp 2214-2222 (2020)
Abstract The aim of this article was to analyse in‐depth the relationship between left ventricular (LV) ejection fraction (EF) (LVEF) and the most commonly used formulas for the calculation of LV elastance (Ees), volume intercept at 0 mmHg pressure
Externí odkaz:
https://doaj.org/article/2f8e78f06e1f4588bc04b83fec71c844
Autor:
Elena-Laura Antohi, Ovidiu Chioncel
Publikováno v:
Exploration of Medicine, Vol 1, Iss 2, Pp 75-84 (2020)
Left ventricular ejection fraction is the critical parameter used for heart failure classification, decision making and assessing prognosis. It is defined as a volumetric ratio and is essentially a composite of arterial and ventricular elastances, bu
Externí odkaz:
https://doaj.org/article/5e94eda1439f4f92b43bf0ad7ae22cd3
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2022)
Left ventricular ejection fraction (LVEF) and ventricular-arterial coupling (VAC) [VAC = Ea/Ees; Ea: effective arterial elastance; Ees: left ventricle (LV) elastance] are both dimensionless ratios with important limitations, especially in heart failu
Externí odkaz:
https://doaj.org/article/8b0c890d6a38456d8aa79a2d751cd907
Autor:
Ovidiu Chioncel, Marianna Adamo, Maria Nikolaou, John Parissis, Alexandre Mebazaa, Mehmet Birhan Yilmaz, Christian Hassager, Brenda Moura, Johann Bauersachs, Veli‐Pekka Harjola, Elena‐Laura Antohi, Tuvia Ben Gal, Sean P. Collins, Vlad Anton Iliescu, Magdy Abdelhamid, Jelena Celutkiene, Stamatis Adamopoulos, Lars H Lund, Mariantonietta Cicoira, Josep Masip, Hadi Skouri, Finn Gustafsson, Amina Rakisheva, Ingo Ahrens, Andrea Mortara, Ewa Jankowska, Abdallah Almaghraby, Kevin Damman, Oscar Miro, Kurt Huber, Arsen Ristic, Loreena Hill, Wilfried Mullens, Alaide Chieffo, Josef Bartunek, Pasquale Paolisso, Antoni Bayes‐Genis, Stefan D Anker, Susanna Price, Gerasimos Filippatos, Frank Ruschitzka, Petar Seferovic, Rafael Vidal Perez, Alec Vahanian, Marco Metra, Theresa A McDonagh, Emanuele Barbato, Andrew JS Coats, Giuseppe MC Rosano
Publikováno v:
European Journal of Heart Failure.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07ba0b4c7bf14d5f7007badc0c0cc650
https://doi.org/10.1002/ejhf.2918
https://doi.org/10.1002/ejhf.2918
Autor:
Òscar Miró, Yuri Lopatin, Alexander R. Lyon, Razvan I. Radu, Andrew P. Ambrosy, Marco Metra, Sean P. Collins, John Parissis, Stefan D. Anker, Elena-Laura Antohi, Oliviana Geavlete, Tuvia Ben Gal, Magdy Abdelhamid, Marianna Adamo, Ovidiu Chioncel
Publikováno v:
ESC Heart Failure, Vol 8, Iss 6, Pp 4717-4736 (2021)
ESC Heart Failure
ESC Heart Failure
Cardiogenic shock (CS) is a complex multifactorial clinical syndrome, developing as a continuum, and progressing from the initial insult (underlying cause) to the subsequent occurrence of organ failure and death. There is a large phenotypic variabili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d30aabf82967f1a38e8149932e4cfdc
https://doaj.org/article/d655f69a7f10400792deeb84af7d8578
https://doaj.org/article/d655f69a7f10400792deeb84af7d8578
Autor:
Andrei George Iosifescu, Toma Andrei Iosifescu, Alina Teodora Timisescu, Elena-Laura Antohi, Vlad Anton Iliescu
Publikováno v:
Tex Heart Inst J
Left ventricular pseudoaneurysm is a rare disease; it is defined as a ventricular rupture contained by epicardium, pericardial adhesions, or both. It most frequently occurs as a complication of acute myocardial infarction. Surgical treatment is recom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ad605dbd1acce5e99d348cedc0af96f
https://doi.org/10.14503/thij-20-7462
https://doi.org/10.14503/thij-20-7462
Autor:
Marco Metra, Francesco Monitillo, Michele Correale, Marta Leone, Hans-Dirk Düngen, Chaudhry M.S. Sarwar, Maurizio Memo, Renata Petroni, Hani N. Sabbah, Stefano Coiro, Javed Butler, Marco Triggiani, Elena-Laura Antohi, Shiro Ishihara, Savina Nodari
Publikováno v:
Heart Failure Reviews. 27:1147-1163
Despite recent advances in chronic heart failure (HF) therapy, the prognosis of HF patients remains poor, with high rates of HF rehospitalizations and death in the early months after discharge. This emphasizes the need for incorporating novel HF drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68699080c1bd2e9097a0dac3d0bd36bf
https://doi.org/10.1007/s10741-021-10107-8
https://doi.org/10.1007/s10741-021-10107-8